Early-stage strategy for healthcare innovation | Kevin Colleran, TJ Parker скачать в хорошем качестве

Early-stage strategy for healthcare innovation | Kevin Colleran, TJ Parker

Kevin Colleran was one of the first ten members of Facebook. Now he's a venture capitalist investing in PillPack, founded by TJ Parker, which is helping everyday people get their medications on time. Here the two discuss early stage strategy for innovative companies. Preeti Nellore Sampat. The MIT Venture Capital + Innovation Conference is held annually in February at the MIT Sloan School of Management. Thank you to our lead sponsor IBM Research, as well as Solvay, Wilmer Hale, Finnegan, The MIT Industrial Liaison Program, the MIT Startup Exchange, and Startup Hub Boston. Visit http://www.mitvcconference.com/. Kevin Colleran is Managing Director of Slow Ventures, an early stage venture capital fund run by a group of early Facebook executives. Slow manages nearly $250 million in capital financed by a group of 100+ tech industry founders, CEO's, executives as well as a select group of notable venture capital firms and endowments. At Slow, Colleran focuses on early stage tech investments in consumer and enterprise startups including Pinterest, Barkbox, Birchbox, Postmates, Nextdoor, Casper, Pillpack, Classpass, Shyp, Breather, Slack, Product Hunt, Evernote, AngelList, Handy, Wealthfront and 180+ other companies. Kevin was also recently a Venture Partner and Advisor at General Catalyst Partners and wrote a column for the Wall Street Journal (online & print) as part of their "Accelerators" section. Previously Kevin was one of the first 10 employees at Facebook Inc. having joined in early 2005 as their first advertising sales person. He stayed at Facebook for nearly 7 years on the revenue team leaving in 2012 after having become the longest tenured employee at the company other than Mark Zuckerberg. TJ Parker is the co-founder and CEO of PillPack. Parker is a second generation pharmacist and holds a Doctor of Pharmacy (PharmD) degree from Massachusetts College of Pharmacy and Health Sciences. He was named one of Forbes' '30 Under 30' in 2015 and Inc Magazine's ‘30 under 30’ "Most Dynamic Young CEOs in America" in 2016.